MedTrace Logo

Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease

NCT06564246 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-12-05

No results posted yet for this study

Summary

This study aims to investigate the possible efficacy of vonoprazan versus Pantoprazole in patients with gastroesophageal reflux disease.

Conditions

  • Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG

Vonoprazan 20 mg versus Pantoprazole 40 mg

Patients divided into two arms First Arm administered vonoprazan Second arm administered pantoprazole

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Aya Hany Abdel Aziz · Master degree student at faculty of pharmacy - Tanta university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-18
Primary Completion
2026-08-31
Completion
2026-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06564246 on ClinicalTrials.gov